Literature DB >> 2120288

In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat.

C Cavard1, A Zider, M Vernet, M Bennoun, S Saragosti, G Grimber, P Briand.   

Abstract

It has been previously shown in vitro that the human immunodeficiency virus type 1 long terminal repeat (LTR) is activated by ultraviolet irradiation. In order to analyze if a similar effect could occur in vivo, transgenic mice carrying the lacZ gene under the control of the viral LTR were irradiated at 280-300 and 254 nm. These mice spontaneously expressed the transgene in the epidermis and the lens of both adults and embryos. Irradiations caused a significant increase in skin beta-galactosidase activity. This phenomenon might be involved in viral activation and could be of interest in regard to the skin pathology observed during an HIV infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120288      PMCID: PMC296873          DOI: 10.1172/JCI114849

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  The human immunodeficiency virus long terminal repeat is preferentially expressed in Langerhans cells in transgenic mice.

Authors:  J Leonard; J S Khillan; H E Gendelman; A Adachi; S Lorenzo; H Westphal; M A Martin; M S Meltzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

Review 2.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.

Authors:  J Vogel; S H Hinrichs; R K Reynolds; P A Luciw; G Jay
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

5.  Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection.

Authors:  J W Gordon; F H Ruddle
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene.

Authors:  K T Jeang; S G Widen; O J Semmes; S H Wilson
Journal:  Science       Date:  1990-03-02       Impact factor: 47.728

7.  Development of disease and virus recovery in transgenic mice containing HIV proviral DNA.

Authors:  J M Leonard; J W Abramczuk; D S Pezen; R Rutledge; J H Belcher; F Hakim; G Shearer; L Lamperth; W Travis; T Fredrickson
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

8.  Activation of human immunodeficiency virus type 1 by DNA damage in human cells.

Authors:  K Valerie; A Delers; C Bruck; C Thiriart; H Rosenberg; C Debouck; M Rosenberg
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

9.  UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells.

Authors:  B Stein; M Krämer; H J Rahmsdorf; H Ponta; P Herrlich
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.

Authors:  B Ensoli; P Lusso; F Schachter; S F Josephs; J Rappaport; F Negro; R C Gallo; F Wong-Staal
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  9 in total

1.  UV activation of human immunodeficiency virus gene expression in transgenic mice.

Authors:  J Vogel; M Cepeda; E Tschachler; L A Napolitano; G Jay
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

Review 2.  Transgenesis in rats: technical aspects and models.

Authors:  B Charreau; L Tesson; J P Soulillou; C Pourcel; I Anegon
Journal:  Transgenic Res       Date:  1996-07       Impact factor: 2.788

Review 3.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

4.  Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents.

Authors:  F Carrier; A Gatignol; M C Hollander; K T Jeang; A J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 5.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

6.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

Authors:  P R Skolnik; B Jahn; M Z Wang; T R Rota; M S Hirsch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

7.  In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice.

Authors:  J D Morrey; S M Bourn; T D Bunch; M K Jackson; R W Sidwell; L R Barrows; R A Daynes; C A Rosen
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Dispensable role of the NF-kappa B sites in the UV-induction of the HIV-1 LTR in transgenic mice.

Authors:  A Zider; B Mashhour; P Fergelot; G Grimber; M Vernet; U Hazan; D Couton; P Briand; C Cavard
Journal:  Nucleic Acids Res       Date:  1993-01-11       Impact factor: 16.971

9.  Tryptophan Metabolism Activates Aryl Hydrocarbon Receptor-Mediated Pathway To Promote HIV-1 Infection and Reactivation.

Authors:  Yan-Heng Zhou; Li Sun; Jun Chen; Wei-Wei Sun; Li Ma; Yang Han; Xia Jin; Qing-Xia Zhao; Taisheng Li; Hongzhou Lu; Xiu Qiu; Jian-Hua Wang
Journal:  mBio       Date:  2019-12-17       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.